These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7662385)

  • 41. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil.
    Yoshiga Y; Shimizu A; Yamagata T; Hayano T; Ueyama T; Ohmura M; Itagaki K; Kimura M; Matsuzaki M
    Circ J; 2002 Nov; 66(11):1024-8. PubMed ID: 12419934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
    Meierhenrich R; Helguera ME; Kidwell GA; Tebbe U
    Int J Cardiol; 1997 Aug; 60(3):289-94. PubMed ID: 9261640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can the assessment of dynamic QT dispersion on exercise electrocardiogram predict sudden cardiac death in hypertrophic cardiomyopathy?
    Yi G; Poloniecki J; Dickie S; Elliott PM; Malik M; McKenna WJ
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1953-6. PubMed ID: 11139965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of QT dispersion with indices used to evaluate the severity of familial ventricular arrhythmias in Boxers.
    Spier AW; Meurs KM; Muir WW; Lehmkuhl LB; Hamlin RL
    Am J Vet Res; 2001 Sep; 62(9):1481-5. PubMed ID: 11560281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QTc dispersion increases during hemodialysis with low-calcium dialysate.
    Näppi SE; Virtanen VK; Saha HH; Mustonen JT; Pasternack AI
    Kidney Int; 2000 May; 57(5):2117-22. PubMed ID: 10792632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of beta-adrenergic blockade on dispersion of ventricular repolarization in newborn infants with prolonged QT interval.
    Stramba-Badiale M; Goulene K; Schwartz PJ
    Am Heart J; 1997 Sep; 134(3):406-10. PubMed ID: 9327695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion.
    Bonnar CE; Davie AP; Caruana L; Fenn L; Ogston SA; McMurray JJ; Struthers AD
    Heart; 1999 Mar; 81(3):297-302. PubMed ID: 10026356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Okeie K; Yamaguchi M; Hayashi K; Nagata M; Itoh H; Iwaki T; Oe K; Konno T; Taki J; Nakajima K; Mabuchi H
    Am Heart J; 2001 Aug; 142(2):358-62. PubMed ID: 11479478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy.
    Akboğa MK; Gülcihan Balcı K; Yılmaz S; Aydın S; Yayla Ç; Ertem AG; Ünal S; Balcı MM; Balbay Y; Aras D; Topaloğlu S
    Anatol J Cardiol; 2017 Jul; 18(1):48-53. PubMed ID: 28315570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.
    Hurtado-de-Mendoza D; Corona-Villalobos CP; Pozios I; Gonzales J; Soleimanifard Y; Sivalokanathan S; Montoya-Cerrillo D; Vakrou S; Kamel I; Mormontoy-Laurel W; Dolores-Cerna K; Suarez J; Perez-Melo S; Bluemke DA; Abraham TP; Zimmerman SL; Abraham MR
    J Arrhythm; 2017 Jun; 33(3):201-207. PubMed ID: 28607615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged ventricular repolarization measured by corrected QT interval (QTc) in subclinical hyperthyroidism.
    Owecki M; Michalak A; Nikisch E; Sowiński J
    Horm Metab Res; 2006 Jan; 38(1):44-7. PubMed ID: 16477540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dispersion of ventricular repolarization in hypertrophic cardiomyopathy.
    Zaidi M; Robert A; Fesler R; Derwael C; Brohet C
    J Electrocardiol; 1996; 29 Suppl():89-94. PubMed ID: 9238384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus.
    Teixeira RA; Borba EF; Pedrosa A; Nishioka S; Viana VS; Ramires JA; Kalil-Filho R; Bonfá E; Martinelli Filho M
    Europace; 2014 Jun; 16(6):887-92. PubMed ID: 24050965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide.
    Garabelli P; Stavrakis S; Albert M; Koomson E; Parwani P; Chohan J; Smith L; Albert D; Xie R; Xie Q; Reynolds D; Po S
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):827-32. PubMed ID: 27027653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability].
    Tatarchenko IP; Pozdniakova NV; Shevyrev VA; Morozova OI
    Kardiologiia; 2003; 43(2):65-8. PubMed ID: 12891276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives.
    Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I
    Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone.
    Fei L; Slade AK; Grace AA; Malik M; Camm AJ; McKenna WJ
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2222-7. PubMed ID: 7845847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis.
    Bozbas H; Atar I; Yildirir A; Ozgul A; Uyar M; Ozdemir N; Muderrisoglu H; Ozin B
    Ren Fail; 2007; 29(3):331-9. PubMed ID: 17497448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The assessment of P-wave dispersion and myocardial repolarization parameters in patients with chronic kidney disease.
    Kollu K; Altintepe L; Duran C; Topal M; Ecirli S
    Ren Fail; 2018 Nov; 40(1):1-7. PubMed ID: 29285964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.